Silver-Based Solution Assists Treatment and Management of Chronic Wounds

The solution may be either applied directly onto the wound or by the disposable DermaStream device, a wound care system that involves the continuous and uniform streaming of therapeutic solutions over the wound bed, while simultaneously removing exudate and infectious material. SilverStream is intended for management and moisturizing of wounds, such as stage I-IV pressure ulcers, stasis ulcers, diabetic foot ulcers, postsurgical wounds, first and second degree burns, cuts, abrasions, and minor skin irritations. DermaSept, an over the counter version of the product, is intended for the management and moisturizing of minor cuts, minor burns, abrasions, and irritated areas. SilverStream, DermaStream, and DermaSept are products of EnzySurge (Rosh Ha'ayin, Israel), and have been approved by the U.S. Food and Drug Administration (FDA).

"We believe that SilverStream is a powerful wound management solution and will be a significant addition to the DermaStream product line, which is intended to become the wound management system of choice,” said Amir Shiner, CEO of EnzySurge. "The recent achievements of EnzySurge, and especially this FDA approval for SilverStream, represent significant opportunities for EnzySurge in the global wound care market in the near future.”

Related Links:
EnzySurge